Cargando…
Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation
Mantle Cell Lymphoma (MCL) is a well-known histological and clinical subtype of B-cell non-Hodgkin's Lymphomas. It is usually characterized by an aggressive disease course, presenting with advanced stage disease at diagnosis and with low response rates to therapy. However few cases of indolent...
Autores principales: | Filippi, Andrea Riccardo, Franco, Pierfrancesco, Galliano, Marco, Ricardi, Umberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569379/ https://www.ncbi.nlm.nih.gov/pubmed/16956411 http://dx.doi.org/10.1186/1748-717X-1-35 |
Ejemplares similares
-
ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)
por: Jiang, Y, et al.
Publicado: (2016) -
New insights into the phenotypic spectrum of 14q22q23 deletions: a case report and literature review
por: Pichiecchio, Anna, et al.
Publicado: (2018) -
Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?
por: Ortega, Veronica, et al.
Publicado: (2021) -
The Evolving Role of Radiotherapy in Early Stage Hodgkin’s Lymphoma
por: Ricardi, Umberto, et al.
Publicado: (2014) -
De novo interstitial deletion of 15q22q23 with global developmental delay and hypotonia: the first Korean case
por: Kim, Ha-Su, et al.
Publicado: (2015)